Search Browse Earnings

CytoDyn Inc. — SlamSEC

CytoDyn Inc.

OTC:CYDY

Pharmaceutical Preparations·VANCOUVER, WA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$266,000

FY 2023

Adj. EBITDA

-$18.0M

-6777.8% margin

FY 2025

Net Income

-$49.8M

-18737.2% margin

FY 2025

EPS (Diluted)

-$0.05

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$3.1M

FY 2025

Total Debt

$2.3M

FY 2015

Net Cash

$771,316

FY 2015

Enterprise Value

—

Debt / EBITDA

0.0x

FY 2023

EV / EBITDA

—

Employees

—

CEO

Lalezari Jacob P

CFO

Hoffman Robert E.